ACTN4 regulates the stability of RIPK1 in melanoma-Reference-Cited by-同舟云学术

ACTN4 regulates the stability of RIPK1 in melanoma

Published:2018-04-30 Issue:29 Volume:37 Page:4033-4045
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zhang Yuan Yuan,Tabataba Hessam,Liu Xiao Ying,Wang Jia Yu,Yan Xu Guang,Farrelly Margaret,Jiang Chen Chen,Guo Su Tang,Liu Tao,Kao Hung-Ying,Thorne Rick F.,Zhang Xu Dong^ORCID,Jin Lei

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0260-x.pdf

Reference48 articles.

1. Hsu KS, Kao HY. Alpha-actinin 4 and tumorigenesis of breast cancer. Vitam Horm. 2013;93:323–51.

2. Honda K. The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer. Cell Biosci. 2015;5:41.

3. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol. 1998;140:1383–93.

4. Djinovic-Carugo K, Gautel M, Ylanne J, Young P. The spectrin repeat: a structural platform for cytoskeletal protein assemblies. FEBS Lett. 2002;513:119–23.

5. Broderick MJ, Winder SJ. Towards a complete atomic structure of spectrin family proteins. J Struct Biol. 2002;137:184–93.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation;Cancer Letters;2024-10

2. PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway;Cell Death & Disease;2023-08-25

3. Placental proteome in late‑onset of fetal growth restriction;Molecular Medicine Reports;2022-10-14

4. LncRNA TP73-AS1 Exacerbates the Non-Small-Cell Lung Cancer (NSCLC) Process via Regulating miR-125a-3p-Mediated ACTN4;Evidence-Based Complementary and Alternative Medicine;2022-09-09

5. RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma;BMC Cancer;2022-05-15